Hepatocerebral Degeneration Latest Advances

Copper-associated Chronic Hepatitis in Dogs.

Journal: The Veterinary clinics of North America. Small animal practice

Published: October 11, 2025

Where do we stand with tetrathiomolybdate as a potential treatment for Wilson disease?

Journal: Journal of hepatology

Published: September 16, 2025

Repurposing Melatonin in dual-mode for Wilson disease therapy as a Copper Chelator and an antioxidant agent.

Journal: bioRxiv : the preprint server for biology

Published: September 15, 2025

Plasma Exchange and Abrogation of Monocyte Activation in Wilson's Disease.

Journal: Clinical and molecular hepatology

Published: September 12, 2025

Systematic review of cardiac ventricular dysfunction in Wilson's disease: mechanisms, diagnostic advancements, and management strategies.

Journal: Future cardiology

Published: September 04, 2025

Expert consensus on the diagnosis and therapy of inherited hyperbilirubinemia (version 2025)

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: August 28, 2025

Widespread Verrucous Nodules in a Child With Wilsons Disease.

Journal: International journal of dermatology

Published: August 23, 2025

Co-existence of acute liver failure and mucormycosis in an immunocompetent host: A rare presentation of Wilson's disease.

Journal: Tropical doctor

Published: August 21, 2025

Molecular Characterization of Wilson's Disease in Liver Transplant Patients: A Five-Year Single-Center Experience in Iran.

Journal: Diagnostics (Basel, Switzerland)

Published: August 19, 2025

A Case of Wilson's Disease With Early Neuropsychiatric and Late Hepatic Manifestations.

Journal: Cureus

Published: August 14, 2025

Corneal Copper Deposits in a Breast Cancer Survivor: A 5-Year Follow-Up.

Journal: Ocular immunology and inflammation

Published: August 13, 2025

TDMQ20 as A Drug Candidate for Wilson's Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice.

Journal: Pharmaceutics

Published: August 12, 2025

Filters

Copper-associated Chronic Hepatitis in Dogs.

Copper-associated Chronic Hepatitis in Dogs.

Where do we stand with tetrathiomolybdate as a potential treatment for Wilson disease?

Where do we stand with tetrathiomolybdate as a potential treatment for Wilson disease?

Repurposing Melatonin in dual-mode for Wilson disease therapy as a Copper Chelator and an antioxidant agent.

Repurposing Melatonin in dual-mode for Wilson disease therapy as a Copper Chelator and an antioxidant agent.

Plasma Exchange and Abrogation of Monocyte Activation in Wilson's Disease.

Plasma Exchange and Abrogation of Monocyte Activation in Wilson's Disease.

Systematic review of cardiac ventricular dysfunction in Wilson's disease: mechanisms, diagnostic advancements, and management strategies.

Systematic review of cardiac ventricular dysfunction in Wilson's disease: mechanisms, diagnostic advancements, and management strategies.

Expert consensus on the diagnosis and therapy of inherited hyperbilirubinemia (version 2025)

Expert consensus on the diagnosis and therapy of inherited hyperbilirubinemia (version 2025)

Widespread Verrucous Nodules in a Child With Wilsons Disease.

Widespread Verrucous Nodules in a Child With Wilsons Disease.

Co-existence of acute liver failure and mucormycosis in an immunocompetent host: A rare presentation of Wilson's disease.

Co-existence of acute liver failure and mucormycosis in an immunocompetent host: A rare presentation of Wilson's disease.

Molecular Characterization of Wilson's Disease in Liver Transplant Patients: A Five-Year Single-Center Experience in Iran.

Molecular Characterization of Wilson's Disease in Liver Transplant Patients: A Five-Year Single-Center Experience in Iran.

A Case of Wilson's Disease With Early Neuropsychiatric and Late Hepatic Manifestations.

A Case of Wilson's Disease With Early Neuropsychiatric and Late Hepatic Manifestations.

Corneal Copper Deposits in a Breast Cancer Survivor: A 5-Year Follow-Up.

Corneal Copper Deposits in a Breast Cancer Survivor: A 5-Year Follow-Up.

TDMQ20 as A Drug Candidate for Wilson's Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice.

TDMQ20 as A Drug Candidate for Wilson's Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice.